History of Antibiotics. From Salvarsan to Cephalosporins
Top Cited Papers
- 22 March 2012
- journal article
- review article
- Published by Informa UK Limited in Journal of Investigative Surgery
- Vol. 25 (2), 67-77
- https://doi.org/10.3109/08941939.2012.664099
Abstract
Infections have represented for a long time the leading cause of death in humans. During the 19th century, pneumonia, tuberculosis, diarrhea and diphtheria were considered the main causes of death in children and adults. Only in the late 19th century did it become possible to correlate the existence of microscopic pathogens with the development of various diseases. Within a few years the introduction of antiseptic procedures had begun to reduce mortality due to postsurgical infections. Sanitation and hygiene played a significant role in the reduction of the mortality due to several infectious diseases. The introduction of the first compounds with antimicrobial activity succeeded in conquering many diseases. In this review we analyzed, from a historical perspective, the development of antibiotics and the circumstances that led to their discovery. The first compound with antimicrobial activity was introduced in 1911 by Erlich. He focused his research activity on the discovery of a “magic bullet” to treat syphilis. Afterwards, Foley and colleagues brought penicillin to the forefront. Streptomycin represents the first drug discovered for the treatment of tuberculosis, and its development included the first use of clinical trials. Finally, with the development of cephalosporins, the introduction of new antimicrobial compounds with broad activity against Gram-positive and also some Gram-negative bacteria began.Keywords
This publication has 103 references indexed in Scilit:
- Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational studyClinical Therapeutics, 2009
- Cefepime: a reappraisal in an era of increasing antimicrobial resistanceExpert Review of Anti-infective Therapy, 2008
- Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae , and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 2008
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- The Classic: Streptomycin, a Substance Exhibiting Antibiotic Activity against Gram-Positive and Gram-Negative BacteriaPublished by Ovid Technologies (Wolters Kluwer Health) ,2005
- A Practical Guide to the Treatment of Complicated Skin and Soft Tissue InfectionsDrugs, 2003
- A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in ChildrenNew England Journal of Medicine, 1990
- Beta-Lactam AntibioticsNew England Journal of Medicine, 1988
- AmoxycillinDrugs, 1975
- Streptomycin: A summary of clinical andexperimental observationsThe Journal of Pediatrics, 1946